Antibiotics

AB023 B is a pentaene macrolide antibiotic produced by Streptomyces sp. SD581 and K9925278. It has the activity against several pathogenic fungi such as black koji and Candida albicans.

Epithienamycin E is a carbapenem antibiotic produced by Streptomyces flavogriseus MA-4434 and MB-4638. It has anti-gram-positive bacteria and anti-gram-negative bacteria activity.

Epithienamycin B is a carbapenem antibiotic produced by Streptomyces flavogriseus MA-4434 and MB-4638. It has anti-gram-positive bacteria and anti-gram-negative bacteria activity.

Epithienamycin D is a carbapenem antibiotic produced by Streptomyces flavogriseus MA-4434 and MB-4638. It has anti-gram-positive bacteria and anti-gram-negative bacteria activity.

Antibiotic AC7230 is a polyether antibiotic produced by Dactylosporangium sp. AC7230. Activity against gram-positive bacteria.

AH-1763 la is an antibiotic produced by Streptomyces cyaneus against herpes virus. Its ED50 against herpes simplex virus type 1 (HSV-1) is 2.1 μg/mL, and its IC50 against Vero cells is 15.2 μg/mL.

2,3-Dihydroxypropyl 16-methylheptadecanoate is an antibiotic produced by Streptomyces sp. OCU-42815. It is a fatty acid ester of glycerol. It has weak anti-bacterial, yeast and fungal activity.

2,3-Dihydroxypropyl 17-methyloctadecanoate is an antibiotic produced by Streptomyces sp. OCU-42815. It is a fatty acid ester of glycerol. It has weak anti-bacterial, yeast and fungal activity.

2,3-Dihydroxypropyl 16-methyloctadecanoate is an antibiotic produced by Streptomyces sp. OCU-42815. It is a fatty acid ester of glycerol. It has weak anti-bacterial, yeast and fungal activity.

2,3-Dihydroxypropyl 18-methylnonadecanoate is an antibiotic produced by Streptomyces sp. OCU-42815. It is a fatty acid ester of glycerol. It has weak anti-bacterial, yeast and fungal activity.

2,3-Dihydroxypropyl 18-methylicosanoate is an antibiotic produced by Streptomyces sp. OCU-42815. It is a fatty acid ester of glycerol. It has weak anti-bacterial, yeast and fungal activity.

AL072 is an antibiotic against Legionella produced by Strepyomyces sp. AL91. It has strong anti-legionella pneumophila activity.

AT-265 is a nucleoside antibiotic produced by Streptomyces rishiensis. It has anti-gram-positive and negative bacteria activity.

AT 2433 A1 is an anti-tumor antibiotic produced by Actinomadura melliaura. It has activity against gram-positive bacteria. It can prolong the survival period of transplanted leukemia P388 mice.

AT 2433 A2 is an anti-tumor antibiotic produced by Actinomadura melliaura. It has activity against gram-positive bacteria.

AT 2433 B1 is an anti-tumor antibiotic produced by Actinomadura melliaura. It has activity against gram-positive bacteria. It can prolong the survival period of transplanted leukemia P388 mice.

AT 2433 B2 is an anti-tumor antibiotic produced by Actinomadura melliaura. It has activity against gram-positive bacteria.

BE-12406 A is an antitumor antibiotic produced by Streptomyces rutrersensis subsp. castelarensis. It has the activity of inhibiting murine P388 leukemia cells (IC50 is 0.8 µmol/L), and has the same activity against vincristine-doxorubicin resistant strains (P388/VCR) (IC50 is 0.2 µmol/L). It can inhibit the growth of S480 ascites carcinoma in mice.

BE-12406 B is an antitumor antibiotic produced by Streptomyces rutrersensis subsp. castelarensis. It has the activity of inhibiting murine P388 leukemia cells (IC50 is 7 µmol/L), and has the same activity against vincristine-doxorubicin resistant strains (P388/VCR) (IC50 is 7 µmol/L). It can inhibit the growth of S480 ascites carcinoma in mice.

BE-19412A is an antitumor antibiotic extracted from the culture medium of Streptomyces sp. A19412. It is toxic to mouse and human tumor cells such as P388, Ehrlich, DLD-1, PC-13, MKN-45 and Colon 26, with IC50 of 0.9-5.4 μg/mL, and can prolong the survival time of CDF1 mice with Ehrlich cancer.